Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Prelude Therapeutics Incorporated, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ImageneBio Inc. June 16, 202699.4%
-
Prelude Therapeutics Incorporated June 14, 202494.2%
-
ImageneBio Inc. June 9, 202368.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 21, 2026 | Prelude Therapeutics Incorporated | Open-market purchase | +1,689,189 | $4.44 | $7,499,999 |
| Apr 21, 2026 | Prelude Therapeutics Incorporated | Open-market purchase | +1,126,126 | $4.44 | $4,999,999 |
| Jul 25, 2025 | ImageneBio Inc. | Option exercise | +379 | — | — |
| Jul 25, 2025 | ImageneBio Inc. | Open-market purchase | +83,611 | $29.90 | $2,499,969 |
| Aug 4, 2023 | ImageneBio Inc. | Grant or award | +153,121 | — | — |
| May 22, 2023 | Prelude Therapeutics Incorporated | Open-market purchase | +869,565 | $5.75 | $4,999,999 |
Questions about David P. Bonita
What boards is David P. Bonita on?
David P. Bonita sits on the boards of ImageneBio Inc. and Prelude Therapeutics Incorporated.
How long has David P. Bonita served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.